Ledger.Open graph →
SEC Form D · filed July 5, 2023

NeuroSense Therapeutics Ltd

Offering
$4.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HERZLIYA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Cary Claiborne · Herzliya, L3DirectorMark Leuchtenberger · Herzliya, L3DirectorNiva Russek-Blum · Herzliya, L3ExecChristine Pelizzari · Herzliya, L3DirectorRevital Mandil-Levin · Herzliya, L3DirectorOr Eisenberg · Herzliya, L3ExecHagit Binder · Herzliya, L3ExecAlon Ben-Noon · Herzliya, L3Exec · DirectorFerenc Tracik · Herzliya, L3ExecCaren Deardorf · Herzliya, L3DirectorCaren Deardorf · Herzliya, L3DirectorMichel Del Buono · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗